Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake

G Coppiello, M Collantes, MS Sirerol-Piquer… - Circulation, 2015 - Am Heart Assoc
G Coppiello, M Collantes, MS Sirerol-Piquer, S Vandenwijngaert, S Schoors, M Swinnen…
Circulation, 2015Am Heart Assoc
Background—Microvascular endothelium in different organs is specialized to fulfill the
particular needs of parenchymal cells. However, specific information about heart capillary
endothelial cells (ECs) is lacking. Methods and Results—Using microarray profiling on
freshly isolated ECs from heart, brain, and liver, we revealed a genetic signature for
microvascular heart ECs and identified Meox2/Tcf15 heterodimers as novel transcriptional
determinants. This signature was largely shared with skeletal muscle and adipose tissue …
Background
Microvascular endothelium in different organs is specialized to fulfill the particular needs of parenchymal cells. However, specific information about heart capillary endothelial cells (ECs) is lacking.
Methods and Results
Using microarray profiling on freshly isolated ECs from heart, brain, and liver, we revealed a genetic signature for microvascular heart ECs and identified Meox2/Tcf15 heterodimers as novel transcriptional determinants. This signature was largely shared with skeletal muscle and adipose tissue endothelium and was enriched in genes encoding fatty acid (FA) transport–related proteins. Using gain- and loss-of-function approaches, we showed that Meox2/Tcf15 mediate FA uptake in heart ECs, in part, by driving endothelial CD36 and lipoprotein lipase expression and facilitate FA transport across heart ECs. Combined Meox2 and Tcf15 haplodeficiency impaired FA uptake in heart ECs and reduced FA transfer to cardiomyocytes. In the long term, this combined haplodeficiency resulted in impaired cardiac contractility.
Conclusions
Our findings highlight a regulatory role for ECs in FA transfer to the heart parenchyma and unveil 2 of its intrinsic regulators. Our insights could be used to develop new strategies based on endothelial Meox2/Tcf15 targeting to modulate FA transfer to the heart and remedy cardiac dysfunction resulting from altered energy substrate usage.
Am Heart Assoc